Mavacamten decreases maximal force and Ca(2+) sensitivity in the N47K-myosin regulatory light chain mouse model of hypertrophic cardiomyopathy

Morbidity and mortality associated with heart disease is a growing threat to the global population, and novel therapies are needed. Mavacamten (formerly called MYK-461) is a small molecule that binds to cardiac myosin and inhibits myosin ATPase. Mavacamten is currently in clinical trials for the tre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Physiol Heart Circ Physiol
Main Authors: Awinda, Peter O., Watanabe, Marissa, Bishaw, Yemeserach, Huckabee, Anna M., Agonias, Keinan B., Kazmierczak, Katarzyna, Szczesna-Cordary, Danuta, Tanner, Bertrand C. W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Physiological Society 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8082789/
https://ncbi.nlm.nih.gov/pubmed/33337957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpheart.00345.2020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados